'Raising our largest fund in this environment reflects the consistency of our approach and the work our teams are doing inside our portfolio companies every day,' said Pete Stavros and Nate Taylor, Global Co-Heads of Private Equity at KKR. The strategy is designed to provide a broad range of financing solutions to middle-market companies, spanning private debt, equity, and hybrid capital, while also investing opportunistically in stressed public credit. 'We are grateful to the BXLS VI investors for their strong support of our strategies and the firm's enduring conviction in the life sciences,' said Nicholas Galakatos, Global Head of Blackstone Life Sciences. Subscribe to our Newsletter to increase your edge. Don't worry about the news anymore, through our newsletter you'll receive weekly access to what is happening. Join 120,000 other PE professionals today.
learn more
